Status:
COMPLETED
Efficacy and Safety of a 1064-nm Nd:YAG Picosecond Laser Versus a 1927-nm Fractional Laser for Atrophic Acne Scars.
Lead Sponsor:
Second Affiliated Hospital of Xi'an Jiaotong University
Conditions:
Acne Scar
Acne Scars - Atrophic
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
Atrophic acne scars are common disfiguring skin problems, especially in the Asian population prone to Post-inflammatory Hyperpigmentation (PIH), and their treatment is highly challenging. 1064 nm micr...
Eligibility Criteria
Inclusion
- Aged between 18 and 40.
- Symmetrical atrophic acne scars on both sides of the face.
Exclusion
- Uncontrolled active acne.
- Pregnant and lactating women.
- Infectious skin diseases at the treatment site.
- Have taken retinoid drugs orally within the past 6 months.
- Photosensitive individuals or those who have used photosensitive drugs within 2 weeks.
- Keloid constitution.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2021
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT07153679
Start Date
January 1 2021
End Date
August 1 2021
Last Update
September 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The second affiliated hospital of Xi'an Jiaotong University
Xi’an, Shanxi, China, 710000